GeneDx Holdings (WGS) Amortization of Deferred Charges (2021 - 2023)

GeneDx Holdings (WGS) has reported Amortization of Deferred Charges for 3 consecutive years, with $130000.0 the latest figure, recorded in Q3 2023.

• On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $130000.0 in Q3 2023; TTM through Sep 2023 was $518000.0, a 14.35% increase from a year earlier, with the FY2022 full-year figure at $518000.0, up 684.85% from the prior year.
• Amortization of Deferred Charges was $130000.0 for Q3 2023 at GeneDx Holdings, up from $129000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $131000.0 in Q4 2022 and troughed at $66000.0 in Q4 2021.
• A 3-year average of $121375.0 and a median of $129000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges surged 98.48% in 2022 and changed 0.0% in 2023, its largest moves.
• Over 3 years, Amortization of Deferred Charges stood at $66000.0 in 2021, then surged by 98.48% to $131000.0 in 2022, then retreated by 0.76% to $130000.0 in 2023.
• The last three Amortization of Deferred Charges figures came in at $130000.0 (Q3 2023), $129000.0 (Q2 2023), and $128000.0 (Q1 2023), per Business Quant data.